<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To assess the immunosuppressive capacity of hyperfractionated total lymphoid irradiation and <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> for transplantation of unmodified allogeneic marrow in sensitized <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> patients </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS AND MATERIALS: From February 1983 to September 1990, 23 multiply transfused <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> patients underwent unmodified bone marrow transplantation from HLA genotypically identical sibling donors following preparation with 6 Gy hyperfractionated total lymphoid irradiation and 160 mg/kg <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">Graft-versus-host disease</z:e> prophylaxis included steroids in one patient, <z:chebi fb="0" ids="44185">methotrexate</z:chebi> in four, <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> in seven, and <z:chebi fb="0" ids="44185">methotrexate</z:chebi>/<z:chebi fb="0" ids="4031">cyclosporine</z:chebi> in 12 </plain></SENT>
<SENT sid="3" pm="."><plain>There were 17 males and 6 females with a median age of 13 (range: 2.5-32) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: One patient died early before engraftment of <z:mp ids='MP_0001794'>bacterial</z:mp> <z:hpo ids='HP_0100806'>sepsis</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Twenty-two patients were evaluable for engraftment </plain></SENT>
<SENT sid="6" pm="."><plain>Three experienced graft failure including one primary, and two late graft failures associated with <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> withdrawal </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> occurred in 7/22 (&gt; or = grade II in 6), and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> in 3/17 patients </plain></SENT>
<SENT sid="8" pm="."><plain>Except for a patient who received total body irradiation for a second transplant, no patient in this series developed interstitial <z:hpo ids='HP_0002090'>pneumonia</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Fifteen patients are alive with follow-up of 38-125 months (median 68) </plain></SENT>
<SENT sid="10" pm="."><plain>The overall actuarial survival at 5 years is 69%, at 8 years it is 60%, with one late <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>The survival of adult patients was similar to that of younger patients (&gt; or = 16 years old: 63%, &lt; 16 years old: 55%) </plain></SENT>
<SENT sid="12" pm="."><plain>The development of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> adversely influenced survival (88% with Grade 0-I, 17% with grade II-IV; p = 0.002) </plain></SENT>
<SENT sid="13" pm="."><plain>No <z:hpo ids='HP_0000821'>hypothyroidism</z:hpo> or <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">secondary malignancies</z:e> have been documented in this series </plain></SENT>
<SENT sid="14" pm="."><plain>CONCLUSION: Pretransplant immunosuppression with 6 Gy of hyperfractionated total lymphoid irradiation and 160 mg/kg CY reduces but does not eliminate the incidence of graft failure in sensitized <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> patients </plain></SENT>
<SENT sid="15" pm="."><plain>The dose and the mode of administration of total lymphoid irradiation in this trial may be associated with a lower incidence of late side effects </plain></SENT>
<SENT sid="16" pm="."><plain>Survival is comparable to that obtained using preparative regimens without radiation </plain></SENT>
</text></document>